VDACs |
voltage-dependent anion channels |
Production of mitochondrial ROS and mitochondrial dysfunction |
[146] |
p53 |
cellular tumor antigen p53 |
System Xc− inhibition |
[147, 148] |
FSP1 |
ferroptosis suppressor protein 1 (a CoQ oxidoreductase, which) |
FSP1 can reduce phospholipid |
[149] |
Panx 1 |
Pannexin 1 |
Panx 1 negatively regulates lipid peroxidation through the MAPK pathway |
[126] |
NRF2 |
nuclear respiratory Factor 2 |
NRF2 can bind to ARE elements in the promoter regions of the target genes |
[150] |
CoQ |
coenzyme Q (a subtract of the oxidoreductase) |
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis |
[151] |
HSPB1 |
heat shock 27 kDa protein 1 |
HSPB1 phosphorylation is negatively regulated and iron-mediated in the production of lipid ROS |
[152] |
VDR |
Vitamin D receptor |
VDR mediates the transcription of GPX4 |
[73] |
NOX |
NADPH oxidase activator |
Produces ROS |
[153, 154] |
TfR1 |
Transferrin receptor protein 1 |
Mediates iron metabolism |
[154, 155] |
ACSL4 |
Acyl-CoA synthetase long-chain family member 4 |
Regulates the synthesis of fatty acyl CoA |
[137, 154] |
CARS |
Cysteinyl-tRNA synthetase |
Involved in the trans-sulfuration and synthesis of GSH |
[156] |
MAPK |
Mitogen-activated protein kinase 1 |
Mediates cellular growth, survival, adhesion, and differentiation |
[157–159] |
NCOA4 |
Nuclear receptor coactivator 4 |
Regulates iron metabolism |
[160–162] |
15LO |
15-lipoxygenases |
Catalyzes the formation of pro-ferroptotic 15-OOH-AA(HpETE) |
[163, 164] |
SLC7A11 |
Cysteine/glutamate antiporter solute carrier family 7 member 11 |
Regulates the uptake of cysteine and the release of glutamate |
[165–167] |
PEBP1 |
Phosphatidylethanolamine-binding protein 1 |
Inhibits the Ras/MEK/ERK cascade |
[168] |
miR-182-5p |
microRNA-182-5p |
miR-182-5p correlates reversely with GPX4 |
[169] |
miR-378a-3p |
microRNA-378a-3p |
miR-378a-3p correlates reversely with SLC7A11 |
[169] |